DekaBank Deutsche Girozentrale - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 184 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$379,000
+31.6%
6,9000.0%0.00%0.0%
Q2 2021$288,000
+2.1%
6,9000.0%0.00%0.0%
Q1 2021$282,000
-11.6%
6,9000.0%0.00%0.0%
Q4 2020$319,000
+11.5%
6,9000.0%0.00%0.0%
Q3 2020$286,000
-26.5%
6,9000.0%0.00%
-50.0%
Q3 2019$389,000
-48.7%
6,900
-50.0%
0.00%
-50.0%
Q2 2019$759,000
+30.6%
13,800
+62.4%
0.00%
+33.3%
Q1 2019$581,000
+116.8%
8,500
+23.2%
0.00%
+50.0%
Q4 2018$268,000
-53.9%
6,900
-18.8%
0.00%
-33.3%
Q3 2018$581,000
-12.1%
8,500
-2.3%
0.00%
-25.0%
Q2 2018$661,000
+45.6%
8,7000.0%0.00%
+33.3%
Q1 2018$454,000
-8.5%
8,700
-2.2%
0.00%
-25.0%
Q4 2017$496,0000.0%8,9000.0%0.00%0.0%
Q3 2017$496,000
-29.3%
8,9000.0%0.00%
-33.3%
Q2 2017$702,000
-4.9%
8,9000.0%0.01%
-14.3%
Q1 2017$738,000
-2.4%
8,900
-7.8%
0.01%
-12.5%
Q4 2016$756,000
+21.3%
9,650
+8.4%
0.01%
+14.3%
Q3 2016$623,000
+80.1%
8,9000.0%0.01%
+75.0%
Q2 2016$346,000
-4.7%
8,900
-4.3%
0.00%0.0%
Q1 2016$363,0009,3000.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
JW Asset Management, LLC 475,755$25,068,00024.71%
Hudson Executive Capital LP 971,000$51,162,00015.09%
Park West Asset Management LLC 1,051,274$55,392,0002.47%
U S GLOBAL INVESTORS INC 19,200$1,012,0000.62%
Capital Impact Advisors, LLC 26,317$1,387,0000.57%
CLARK ESTATES INC/NY 56,278$2,965,0000.47%
IRIDIAN ASSET MANAGEMENT LLC/CT 873,131$46,005,0000.41%
ProQuest Associates IV LLC 6,777$357,0000.41%
Granite Investment Partners, LLC 114,207$6,017,0000.40%
GLOBEFLEX CAPITAL L P 30,900$1,628,0000.34%
View complete list of EAGLE PHARMACEUTICALS INC shareholders